Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates.

The Journal of antimicrobial chemotherapy - 1 Jul 2010

Knops Elena, Däumer Martin, Awerkiew Sabine, Kartashev Vladimir, Schülter Eugen, Kutsev Sergey, Brakier-Gingras Léa, Kaiser Rolf, Pfister Herbert, Verheyen Jens

Abstract excerpt

OBJECTIVES: To analyse HIV Gag cleavage site (CS) and non-CS mutations in HIV non-B isolates from patients failing antiretroviral therapy. PATIENTS AND METHODS: Twenty-one HIV isolates were obtained from patients infected with HIV subtype G during an outbreak in Russia 20 years ago. Most patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to gag Gene Products, Human Immunodeficiency Virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation, Missense

Share to pol Gene Products, Human Immunodeficiency Virus

Share to Protease Inhibitors

Share to Russia

Source

Identifiers

PMID: 20430786
DOI: 10.1093/jac/dkq129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20430786-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates.PMID 20430786Read ↗

Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1.Semantic proximity Read ↗

Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.Semantic proximity Read ↗

Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India.Semantic proximity Read ↗

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.Semantic proximity Read ↗

Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates.Semantic proximity Read ↗

Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss.Semantic proximity Read ↗

Polymorphisms in HIV-1 subtype C proteases and the potential impact on protease inhibitors.Semantic proximity Read ↗

Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern FranceSemantic proximity Read ↗

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays.Semantic proximity Read ↗

Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis.Semantic proximity Read ↗

Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy.Semantic proximity Read ↗

Role of Gag in HIV Resistance to Protease InhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.